{
  "items": [
    {
      "title": "Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know",
      "description": "In the most recent trading session, Johnson & Johnson (JNJ) closed at $155.22, indicating a -1.2% shift from the previous trading day.",
      "published_utc": "2025-06-17T05:45:02",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=b7c7459e7488eb085034f9d17d490d4ceff55e080edd6791ad6ad911af7c327a",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 135314385,
      "datetime": 1750110302
    },
    {
      "title": "Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q1 2025 Update",
      "description": "AQR Capital's Q1'25 portfolio hits $97.07B, with top picks in AAPL, NVDA, & AMZN. Active portfolio adjustments show a quantitative, diversified approach. See more.",
      "published_utc": "2025-06-17T05:09:43",
      "source": "SeekingAlpha",
      "url": "https://finnhub.io/api/news?id=51b45bd42e92498ec52abd010edf461044394127b04a8428f9c402a3b43b4ef8",
      "category": "company",
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 135312158,
      "datetime": 1750108183
    },
    {
      "title": "Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?",
      "description": "JNJ's Innovative Medicines unit shows a growth trend, defying Stelara LOE and the negative impact of the Part D redesign.",
      "published_utc": "2025-06-16T21:00:00",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=5f33d906adc1b592893ec7877c438cb630f84195085347af1aa3d983c53d2697",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 135314386,
      "datetime": 1750078800
    },
    {
      "title": "J&J reports results from antibody combo trial for MM patients",
      "description": "The investigational combo resulted in an ORR of 78.9%, with over half of the subjects achieving a complete response or better.",
      "published_utc": "2025-06-16T19:43:01",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=e857eac44426e3deff3c9c58c92212550c83ed8861c68c5e26ae6e3a8931bf62",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 135300768,
      "datetime": 1750074181
    },
    {
      "title": "Johnson & Johnsons Dual Targeting Car T Cell Therapy Shows Encouraging First Results In Large B Cell Lymphoma",
      "description": "the most common type of aggressive lymphoma, a blood cancer that originates in the lymphatic system.1,2 These data were presented as an oral presentation at the 2025 European Hematology Association ...",
      "published_utc": "2025-06-16T17:17:29",
      "source": "Finnhub",
      "url": "https://finnhub.io/api/news?id=c087a0d712d780b2a880f3b6cd10b6c9ca9fb7e59f68afa1016252b742b658f2",
      "category": "company",
      "image": "",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 135300797,
      "datetime": 1750065449
    }
  ],
  "metadata": {
    "cached_at": "2025-09-25T07:57:10.107477+00:00",
    "cache_key": "news_c89946780409a251144c65307bb6c873",
    "count": 5
  }
}